Xcytrin (motexafin gadolinum) / AbbVie 
Welcome,         Profile    Billing    Logout  

2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Xcytrin (motexafin gadolinum) / AbbVie
NCT01562223: Studying Repeated DCE-MRI and DWI in Patients Diagnosed With Prostate Cancer

Active, not recruiting
N/A
30
US
motexafin gadolinium, Gadolinium
American College of Radiology Imaging Network, National Cancer Institute (NCI)
Prostate Cancer
12/22
12/22
ACRIN6690, NCT01082224: Contrast-Enhanced CT and MRI in Diagnosing and Staging Liver Cancer Using UNOS Policy

Active, not recruiting
N/A
440
US
iodinated contrast dye, iodinated radiographic dye, motexafin gadolinium, Xcytrin, Eovist-enhanced MRI
American College of Radiology Imaging Network, National Cancer Institute (NCI)
Liver Cancer
12/23
12/23

Download Options